Skip to main content
. 2021 May 19;12:656459. doi: 10.3389/fpsyt.2021.656459

Table 2.

Participant demographics for short and long illness duration.

Short Long
Mean Age (years ± stdev)** 24.3 ± 3.9 43.1 ± 11.0
Gender (M/F) 13/6 10/11
Mean Education Level (years ± stdev) 13.1 ± 1.0 12.8 ± 2.0
Smoking Status (Yes/No) 4/19 7/21
Mean Illness Duration (years ± stdev) 2.7 ± 1.7 21.2 ± 10.3
Cognitive Variables
   Matrics Composite Score (mean ± stdev) 32.7 ± 13.4 24.6 ± 13.7
   UPSA Score (mean ± stdev) 94.6 ± 13.2 80.7 ± 22.3
   LOF Score (mean ± stdev) 24.7.2 ± 4.4 21.9 ± 5.7
Symptom Ratings
   BPRS total score (mean ± stdev) 37.2 ± 6.8 39.0 ± 9.2
   BPRS positive score (mean ± stdev) 7.1 ± 3.3 8.6 ± 3.7
   BPRS negative score (mean ± stdev) 6.7 ± 2.3 6.9 ± 2.3
   BNSS score (mean ± stdev) 14.1 ± 9.2 18.2 ± 11.3
Chlorpromazine Equivalents (mean ± stdev) 290.9 ± 286.0 372.8 ± 362.8
**

statistically significant (p < 0.05).